Class 2 medicine recallHigh riskMedicine · 12 Mar 2024
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
Class 2 medicine recallHigh riskMedicine · 21 Feb 2024
Novartis Pharmaceuticals UK Limited is recalling Adakveo 10 mg/ml concentrate for solution for infusion due to the benefit-risk balance of Adakveo no longer being considered favourable by the MHRA.
Class 2 medicine recallHigh riskMedicine · 30 Aug 2023
Veriton Pharma Limited is recalling a specific batch of Epistatus (midazolam) 2.5mg Oromucosal Solution (pre-filled oral syringes) due to confirmed out of specification results related to the product appearance.
Class 2 medicine recallHigh riskMedicine · 21 Aug 2023
medac GmbH (t/a medac Pharma LLP) is recalling further batches due to particles detected during long-term stability tests.
Class 2 medicine recallHigh riskMedicine · 31 Jul 2023
B. Braun Medical Limited is recalling various product batches as a precautionary measure after traces of midazolam were detected in the batches listed in this notification.
Class 2 medicine recallHigh riskMedicine · 20 Jul 2023
medac GmbH (t/a medac Pharma LLP) is recalling the products and respective batches in this notification due to particles detected during long-term stability tests.
Class 2 medicine recallHigh riskMedicine · 13 Jul 2023
Sanofi UK is recalling the listed batches of Sabril tablets and Sabril granules as a precautionary measure due to the detection of traces of tiapride in the batches of the source material of manufacturer…

Class 2 medicine recallHigh riskMedicine · 10 Jul 2023
Tillomed Laboratories Limited is recalling one batch of Labetalol 200mg Tablets due to an error on the foil blister packaging.
Class 2 medicine recallHigh riskMedicine · 4 Jul 2023
medac GmbH (t/a medac Pharma LLP) is recalling the products and respective batches in this notification due to pink discolouration of the dacarbazine solution immediately after reconstitution (after correct preparation and storage).

Class 2 medicine recallHigh riskMedicine · 23 Mar 2023
Ferring Pharmaceuticals Limited is recalling certain batches of GONAPEPTYL Depot 3.75mg due to a defect noticed in the seal of the needle wrapping for the CE-marked 30-millimeter (30mm) needle for subcutaneous injection that is…
Class 2 medicine recallHigh riskMedicine · 14 Mar 2023
Following the conclusion of a review of post-marketing safety data by the MHRA, all pholcodine-containing medicines are being recalled and withdrawn from the UK as a precaution.
Class 2 medicine recallHigh riskMedicine · 2 Mar 2023
Teva UK Limited is recalling one batch of Levothyroxine 12.5mcg Tablets in response to a lower than required assay result discovered during routine stability testing.
Class 2 medicine recallHigh riskMedicine · 18 Jan 2023
UCB Pharma Ltd is recalling one batch of Dioctyl 100 mg Capsules as a precautionary measure due to the presence of a foreign capsule being found in a sealed pack.
Class 2 medicine recallHigh riskMedicine · 20 Oct 2022
hameln pharma ltd is initiating a recall of the affected batches of Ephedrine Hydrochloride 30 mg/ml Solution for Injection as a precautionary measure.
Class 2 medicine recallHigh riskMedicine · 11 Oct 2022
hameln pharma ltd is initiating a recall of batch 210505 of Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion as a precautionary measure
Class 2 medicine recallHigh riskMedicine · 6 Oct 2022
Sanofi is recalling all batches of Stemetil 5mg/5ml Syrup as a precautionary measure due to the identification of N-nitrosomethylphenylamine (NMPA) above the acceptable limit.

Class 2 medicine recallHigh riskMedicine · 20 Sep 2022
Novartis Pharmaceuticals UK are recalling a batch of Sandimmun Oral Solution due to the presence of crystals in the solution.
Class 2 medicine recallHigh riskMedicine · 30 Aug 2022
Hikma Pharmaceuticals USA Inc are recalling the below batches due to an out of specification result with related substances during testing for retain samples.
Class 2 medicine recallHigh riskMedicine · 22 Aug 2022
The UK Marketing Authorisation Holder has confirmed that a batch of Dysport 500 Units Powder for Solution for Injection is falsified and has been supplied by unauthorised distributors to the UK.
Class 2 medicine recallHigh riskMedicine · 11 Aug 2022
Sun Pharmaceuticals are recalling batches of zoledronic acid due to out of specification results observed for Particulate Matter Test during routine stability testing.
Class 2 medicine recallHigh riskMedicine · 19 Jul 2022
hameln pharma ltd is initiating a recall of batch 207506 of Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion as a precautionary measure.
Class 2 medicine recallHigh riskMedicine · 13 Jun 2022
Bristol Laboratories Limited are recalling a batch of this product as a precautionary measure due to low dissolution test results reported during ongoing stability studies.
Class 2 medicine recallHigh riskMedicine · 25 May 2022
hameln pharma ltd are recalling batches of product additional to the batch recalled on 15 February 2022 (reference EL(22)A/06).
Class 2 medicine recallHigh riskMedicine · 17 May 2022
Quadrant Pharmaceuticals Ltd are recalling a specific batch of Mefenamic Acid 500mg Film-Coated Tablets as a precautionary measure, due to observations of a defective layer of film coating in some tablets, resulting in the…